Gary Patou, Director: Xenon Pharmaceuticals XENE Sell · Filed 23/12/15

Trade details

Type: Insider sale
Amount: $311,897.9
Shares · price: 7,598 sh · $41.05 a share
Held after: 4,902 sh
Stock: Xenon Pharmaceuticals XENE
Person: Gary PatouDirector
Trade date: 23/12/14
Filed: 23/12/15
Days to filing: 1 days

Sold 60.8% of holdings

Share of holding sold: 60.8%

Xenon Pharmaceuticals trades, last 26 weeks

What else happened in Xenon Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/11/14~24/01/13

Gary Patou's recent trades

Gary PatouDirector
Sell10b5-1 planXenon Pharmaceuticals
Sell10b5-1 plan
Xenon Pharmaceuticals
XENE
$70.3K
1,322 sh
$70.3K
Filed 06/08
Traded 06/05
Gary PatouDirector
Planned sale10b5-1 planXenon Pharmaceuticals
Planned sale10b5-1 plan
Xenon Pharmaceuticals
XENE
$70.1K
1,322 sh
$70.1K
Filed 06/05
Traded 06/05
Gary PatouDirector
SellXenon Pharmaceuticals
Sell
Xenon Pharmaceuticals
XENE
$117.2K
2,851 sh
$117.2K
Filed 24/11/22
Traded 24/11/22
Gary PatouDirector
SellXenon Pharmaceuticals
Sell
Xenon Pharmaceuticals
XENE
$83.7K
2,040 sh
$83.7K
Filed 24/11/22
Traded 24/11/22
Gary PatouDirector
SellXenon Pharmaceuticals
Sell
Xenon Pharmaceuticals
XENE
$311.9K
7,598 sh
$311.9K
Filed 23/12/15
Traded 23/12/13